Baseline hypertension: new insight into the potential predictors of survival in patients with hepatocellular carcinoma

Int J Cardiol. 2013 Oct 3;168(3):2979-81. doi: 10.1016/j.ijcard.2013.04.106. Epub 2013 May 7.

Authors

Yu-Feng Hu¹, Tzu-Chi Chen, Gar-Yang Chau, Tsung-Lin Yang, Chia-Jen Liu, Ming-Huang Chen, Peter Mu-Hsin Chang, Tzeng-Ji Chen, Michael Hsiao, Chi-Ying F Huang, Shih-Ann Chen

Affiliation

¹ Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.

PMID: 23659881
DOI: 10.1016/j.ijcard.2013.04.106

No abstract available

Keywords: Barcelona Clinic Liver Cancer stage; CRKL; Mortality; Predictive marker of HCC; VEGFR-1.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Hepatocellular / complications*
Carcinoma, Hepatocellular / mortality*
Humans
Hypertension / complications*
Liver Neoplasms / complications*
Liver Neoplasms / mortality*
Prognosis
Survival Rate